3 Personal Care Company, Off Highway Tyres Maker and Pharmaceuticals Company Stocks With a Strong Future Roadmap: Godrej Consumer Products, Balkrishna Industries and Alembic Pharmaceuticals
- November 13, 2026
- Posted by: Lakshit Sharma
- Category: Best Stocks
Godrej Consumer Products, Balkrishna Industries and Alembic Pharmaceuticals: ROE of 11.3% to 14.7% and FY22 to FY26 revenue CAGR of 5.7% to 8.4%. Prices as of 12 Nov 2026.
Quick Answer
The three personal care, farm tyre and pharma stocks to watch are Godrej Consumer Products, Balkrishna Industries and Alembic Pharmaceuticals. Their return on equity ranges from 11.3% to 14.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 5.7% to 8.4%. Godrej Consumer Products has the highest return on equity at 14.7%, while Alembic Pharmaceuticals has the fastest revenue growth at 8.4% a year. Prices are based on the 12 November 2026 close, and this article is educational, not investment advice.
Personal care, farm tyre and pharma stocks give investors a way to track businesses that sit close to everyday demand in India. Godrej Consumer Products, Balkrishna Industries and Alembic Pharmaceuticals cover a personal care company, an off highway tyres maker and a pharmaceuticals company.
This list covers three personal care, farm tyre and pharma stocks with complete current figures: Godrej Consumer Products, Balkrishna Industries and Alembic Pharmaceuticals. Every figure comes from the latest reported financials and the 12 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Personal Care, Farm Tyre and Pharma Stocks?
Personal care, farm tyre and pharma stocks are listed companies that sell soaps, hair colour and home care products across India and abroad, make tyres for farm, construction and mining vehicles, and make medicines for global and domestic markets. Their earnings depend on household demand, off highway vehicle demand and medicine demand.
Personal Care, Farm Tyre and Pharma Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| Godrej Consumer Products | 876.5 | 84,893 | 44.4 | 32.8 | 14.7 | 0.35 |
| Balkrishna Industries | 2,296.7 | 40,791 | 29.0 | 19.2 | 11.3 | 0.38 |
| Alembic Pharmaceuticals | 1,047.25 | 14,914 | 21.6 | 35.7 | 11.9 | 0.25 |
On valuation, Alembic Pharmaceuticals trades at a P/E below the industry P/E, while Godrej Consumer Products and Balkrishna Industries trade above it, which reflects the growth the market already expects. Readers comparing personal care, farm tyre and pharma stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in personal care, farm tyre and pharma stocks can use the coming numbers to test whether growth is holding.
Why Do Personal Care, Farm Tyre and Pharma Stocks Have a Strong Roadmap in India?
Personal care, farm tyre and pharma stocks have a strong roadmap in India because steady household spending, growing demand for tractors and earthmovers and wider access to medicines keep widening the market for these companies.
- Personal care. Households buy trusted daily brands.
- Off highway tyres. Farm and mining vehicles need strong tyres.
- Pharmaceuticals. Patients need quality medicines.
Why Godrej Consumer Products Features Among These Personal Care, Farm Tyre and Pharma Stocks
Among the personal care, farm tyre and pharma stocks on this list, Godrej Consumer Products is a Mumbai-based consumer goods company that sells household insecticides, soaps, hair colour and air care products in India, Indonesia and Africa.
The company has a return on equity of 14.7%, a debt to equity ratio of 0.35 and a market capitalisation of Rs 84,893 crore. The stock trades at a P/E of 44.4, above the industry P/E of 32.8.
Revenue rose from Rs 12,366 crore in FY22 to Rs 15,444 crore in FY26, a compound annual growth rate of 5.7%. Net profit for FY26 was Rs 1,861 crore, a net margin of 12.1%. In the June 2026 quarter, revenue grew 14.2% year on year to Rs 4,277 crore, while net profit rose 11.5% to Rs 505 crore.
Roadmap: The company is widening its home care and personal care ranges and strengthening its presence in Africa and Indonesia. Well known brands and wide distribution give it steady repeat demand.
What to watch: Monitor volume growth, raw material costs and progress in international markets.
Why Balkrishna Industries Features Among These Personal Care, Farm Tyre and Pharma Stocks
Among the soap and hair colour, farm tyre and medicine shares on this list, Balkrishna Industries makes off-highway tyres for agriculture, construction, mining and industrial vehicles under the BKT brand, and it sells mostly to customers across Europe, the United States and other markets.
Revenue rose from Rs 8,733 crore in FY22 to Rs 11,075 crore in FY26, a compound annual growth rate of 6.1%. Net profit grew from Rs 1,057 crore in FY23 to Rs 1,243 crore in FY26, which works out to a compound annual growth rate of 5.5%.
In the June 2026 quarter, revenue grew 24.0% year on year to Rs 3,555 crore, while net profit rose 56.4% to Rs 451 crore. The company has a return on equity of 11.3%, a debt to equity ratio of 0.38 and a market capitalisation of Rs 40,791 crore. The stock trades at a P/E of 29.0, above the industry P/E of 19.2.
Roadmap: The company benefits from global demand for specialised farm and earthmoving tyres and from its growing brand presence abroad. A focus on niche segments helps it earn healthy margins from export customers.
What to watch: Track export orders, carbon black and rubber costs and progress on new capacity.
Why Alembic Pharmaceuticals Features Among These Personal Care, Farm Tyre and Pharma Stocks
Among the three companies on this list, Alembic Pharmaceuticals is a Vadodara-based drug maker that sells generic formulations in the United States, branded medicines in India and active ingredients to other manufacturers.
In the June 2026 quarter, revenue grew 26.1% year on year to Rs 2,165 crore, while net profit rose 12.2% to Rs 172 crore. Revenue rose from Rs 5,356 crore in FY22 to Rs 7,399 crore in FY26, a compound annual growth rate of 8.4%.
Net profit grew from Rs 521 crore in FY22 to Rs 671 crore in FY26, which works out to a compound annual growth rate of 6.5%. The company has a return on equity of 11.9%, a debt to equity ratio of 0.25 and a market capitalisation of Rs 14,914 crore. The stock trades at a P/E of 21.6, below the industry P/E of 35.7.
Roadmap: The company is moving into complex generics such as injectables and ophthalmic products, which tend to face less competition. Steady growth in the India branded business adds stability.
What to watch: Follow new approvals in the United States, the pace of complex generic launches and domestic growth.
Godrej Consumer Products vs Balkrishna Industries vs Alembic Pharmaceuticals on Key Financials
The table below sets the three personal care, farm tyre and pharma stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| Godrej Consumer Products | 12,366 | 15,444 | 5.7% | 1,861 | 12.1% |
| Balkrishna Industries | 8,733 | 11,075 | 6.1% | 1,243 | 11.2% |
| Alembic Pharmaceuticals | 5,356 | 7,399 | 8.4% | 671 | 9.1% |
Godrej Consumer Products posts the highest return on equity in this group at 14.7%. Godrej Consumer Products has the largest FY26 revenue at Rs 15,444 crore, and Alembic Pharmaceuticals shows the fastest revenue growth with a 8.4% compound annual rate. A useful habit with personal care, farm tyre and pharma stocks is to check each new quarterly result against the capacity plans the company described earlier. Many investors spread money across several household brands, tyres for tractors and formulations stocks instead of one name, which keeps a single result from deciding the outcome.
The June 2026 quarter, the latest reported, gives a fresh read on momentum:
| Company | Q1 FY26 Revenue (Rs Cr) | Q1 FY27 Revenue (Rs Cr) | Year-on-Year Growth |
|---|---|---|---|
| Godrej Consumer Products | 3,746 | 4,277 | 14.2% |
| Balkrishna Industries | 2,867 | 3,555 | 24.0% |
| Alembic Pharmaceuticals | 1,717 | 2,165 | 26.1% |
Key Risks to Check Before Investing in Personal Care, Farm Tyre and Pharma Stocks
Every theme carries risks that deserve a check before any decision. For these personal care, farm tyre and pharma stocks, the main points are: Long-term soap and hair colour, farm tyre and medicine shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Raw material costs. Ingredient and packaging prices can move margins.
- Currency moves. Export earnings move with the rupee.
- Regulatory approvals. Plant inspections and approvals can affect supplies.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter personal care, farm tyre and pharma stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Personal Care, Farm Tyre and Pharma Stocks
Personal care, farm tyre and pharma stocks work best when investors track growth, valuation and return on equity side by side. Godrej Consumer Products, Balkrishna Industries and Alembic Pharmaceuticals each have a clear plan to grow. Based on the 12 November 2026 close, Godrej Consumer Products trades at Rs 876.5, Balkrishna Industries at Rs 2,296.7 and Alembic Pharmaceuticals at Rs 1,047.25. Valuation matters as much as growth, so compare each company’s P/E with its industry P/E before adding any of these personal care, farm tyre and pharma stocks to a watchlist.
Download the Univest iOS App or Univest Android App to track personal care, farm tyre and pharma stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are personal care, farm tyre and pharma stocks?
Ans. Personal care, farm tyre and pharma stocks are listed companies that sell soaps, hair colour and home care products across India and abroad, make tyres for farm, construction and mining vehicles, and make medicines for global and domestic markets. Their earnings depend on household demand, off highway vehicle demand and medicine demand. This list looks at three of them, Godrej Consumer Products, Balkrishna Industries and Alembic Pharmaceuticals, using reported FY22 to FY26 financials and the 12 November 2026 closing prices.
Which personal care, farm tyre and pharma stocks are covered in this list?
Ans. This list covers Godrej Consumer Products, Balkrishna Industries and Alembic Pharmaceuticals. Based on the 12 November 2026 close, Godrej Consumer Products traded at Rs 876.5, Balkrishna Industries at Rs 2,296.7 and Alembic Pharmaceuticals at Rs 1,047.25. Their return on equity ranges from 11.3% to 14.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 5.7% to 8.4%.
Why do personal care, farm tyre and pharma stocks have a strong future roadmap in India?
Ans. Personal care, farm tyre and pharma stocks have a strong roadmap in India because steady household spending, growing demand for tractors and earthmovers and wider access to medicines keep widening the market for these companies. The main drivers are as follows. Personal care. Households buy trusted daily brands. Off highway tyres. Farm and mining vehicles need strong tyres. Pharmaceuticals. Patients need quality medicines. Together these factors give the companies on this list a visible path for growth over the coming years.
How has Godrej Consumer Products performed financially?
Ans. Revenue rose from Rs 12,366 crore in FY22 to Rs 15,444 crore in FY26, a compound annual growth rate of 5.7%. Net profit for FY26 was Rs 1,861 crore, a net margin of 12.1%. In the June 2026 quarter, revenue grew 14.2% year on year to Rs 4,277 crore, while net profit rose 11.5% to Rs 505 crore. The company has a return on equity of 14.7%, a debt to equity ratio of 0.35 and a market capitalisation of Rs 84,893 crore. The stock trades at a P/E of 44.4, above the industry P/E of 32.8. Looking ahead, the company is widening its home care and personal care ranges and strengthening its presence in Africa and Indonesia. Well known brands and wide distribution give it steady repeat demand.
How has Balkrishna Industries performed financially?
Ans. Revenue rose from Rs 8,733 crore in FY22 to Rs 11,075 crore in FY26, a compound annual growth rate of 6.1%. Net profit grew from Rs 1,057 crore in FY23 to Rs 1,243 crore in FY26, which works out to a compound annual growth rate of 5.5%. In the June 2026 quarter, revenue grew 24.0% year on year to Rs 3,555 crore, while net profit rose 56.4% to Rs 451 crore. The company has a return on equity of 11.3%, a debt to equity ratio of 0.38 and a market capitalisation of Rs 40,791 crore. The stock trades at a P/E of 29.0, above the industry P/E of 19.2. Looking ahead, the company benefits from global demand for specialised farm and earthmoving tyres and from its growing brand presence abroad. A focus on niche segments helps it earn healthy margins from export customers.
How has Alembic Pharmaceuticals performed financially?
Ans. Revenue rose from Rs 5,356 crore in FY22 to Rs 7,399 crore in FY26, a compound annual growth rate of 8.4%. Net profit grew from Rs 521 crore in FY22 to Rs 671 crore in FY26, which works out to a compound annual growth rate of 6.5%. In the June 2026 quarter, revenue grew 26.1% year on year to Rs 2,165 crore, while net profit rose 12.2% to Rs 172 crore. The company has a return on equity of 11.9%, a debt to equity ratio of 0.25 and a market capitalisation of Rs 14,914 crore. The stock trades at a P/E of 21.6, below the industry P/E of 35.7. Looking ahead, the company is moving into complex generics such as injectables and ophthalmic products, which tend to face less competition. Steady growth in the India branded business adds stability.
What risks should investors check before buying personal care, farm tyre and pharma stocks?
Ans. Investors should check a few risks before buying personal care, farm tyre and pharma stocks. Raw material costs. Ingredient and packaging prices can move margins. Currency moves. Export earnings move with the rupee. Regulatory approvals. Plant inspections and approvals can affect supplies. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of personal care, farm tyre and pharma stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 12 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.